Semaglutide vs Naltrexone for Alcohol: How the Two Actually Compare

Semaglutide and naltrexone both reduce the pull toward alcohol, but they work through completely different receptors, and only one of them is FDA-approved for drinking.

What You'll Discover:

• What each molecule actually does inside the brain.

• Where the FDA stands on semaglutide and on naltrexone.

• How the two bodies of evidence compare in size and maturity.

• What side effects, cost, and access look like day to day.

• Why some people end up taking both under one physician.

Two medications keep coming up when people start thinking about drinking less. One has been prescribed for alcohol since 1994. The other was built for blood sugar and weight, and people noticed it quieted their urge to drink almost by accident.

Both are legitimate options. They are not interchangeable, and the honest comparison is far more useful than the headlines on either side.

Two Molecules, Two Completely Different Jobs

The clearest way to understand the difference is to look at what each molecule attaches to. They are not competing for the same receptor. They are barely in the same neighborhood.

What Naltrexone Does in the Brain

Naltrexone is an opioid antagonist. It parks on mu-opioid receptors and blocks them without switching them on.

That matters for drinking because alcohol prompts a release of endorphins, and those endorphins land on the exact receptors naltrexone is occupying. Normally that triggers a dopamine surge in a brain region called the nucleus accumbens.

That surge is the buzz. It is the "one more" feeling, and it is a big part of why the second drink follows the first so easily.

With naltrexone in your system, the endorphins arrive and find the door locked. The alcohol still reaches your bloodstream and you still feel it, but the reward signal is muted.

Drink after drink, week after week, the brain stops linking alcohol with a payoff. People describe it plainly. The drink just does not do much anymore.

Oral naltrexone is a 50mg tablet taken once a day. It hits peak concentration in about an hour and stays active for roughly 20 to 22 hours, with the metabolite 6-beta-naltrexol stretching some of that effect further.

What Semaglutide Does in the Brain and the Gut

Semaglutide belongs to a class called GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after you eat. It cues insulin release, slows how fast your stomach empties, and tells your brain you have had enough.

Semaglutide is a long-acting synthetic version of that hormone. It was designed for type 2 diabetes and later approved for chronic weight management, which is why most people know it as Ozempic or Wegovy.

The alcohol connection comes from where else GLP-1 receptors turn up. They sit in brain regions tied to reward and motivation, including the ventral tegmental area and that same nucleus accumbens.

When those receptors get activated, the pull of rewarding things appears to weaken. People on GLP-1 medications talk about less "food noise," and a meaningful subset describe the same quieting around alcohol.

So naltrexone works downstream of the drink by blunting what you get out of it. Semaglutide seems to work upstream by lowering how much you wanted it in the first place.

Different levers. Similar destination.

Where the FDA Stands on Each Medication

This is the most important practical difference between the two, and it gets skipped over constantly.

Naltrexone has been FDA-approved for alcohol dependence since 1994. The agency reviewed trial data specifically for drinking outcomes and cleared it for that purpose.

The StatPearls pharmacology reference on naltrexone walks through the approved indications, dosing, half-life, and monitoring in detail.

Semaglutide is FDA-approved for type 2 diabetes and for chronic weight management. It is not approved for alcohol use disorder.

The StatPearls entry on semaglutide covers its cleared uses along with its warnings, including the boxed warning about thyroid C-cell tumors observed in rodent studies.

Using semaglutide to reduce drinking is off-label. Off-label prescribing is legal, common, and often good medicine. It also means insurance almost never pays for it on that basis, and the safety data specific to heavy drinkers is still being built.

That gap is not a reason to dismiss GLP-1 medications. It is a reason to have the conversation with a physician instead of a forum.

Semaglutide vs Naltrexone at a Glance

How Strong Is the Evidence Behind Each One

Both medications have research behind them. The volume and maturity of that research are not close, and pretending otherwise does nobody any favors.

Naltrexone's Track Record

Naltrexone has been through controlled trials for three decades. A systematic review and network meta-analysis of alcohol use disorder medications found that oral naltrexone improved total abstinence compared with placebo and cut heavy drinking.

The effects are consistent rather than theatrical. Pooled analyses put the number needed to treat at roughly 11 to keep one person from returning to heavy drinking, which is a strong showing for any chronic condition medication.

For context, aspirin taken to prevent a first heart attack has a number needed to treat closer to 100. Naltrexone is doing real work.

The National Institute on Alcohol Abuse and Alcoholism describes naltrexone as reducing cravings and blunting the rewarding effects of drinking, taken once daily.

Most people notice something within two to four weeks. That timeline shows up across trials and matches what patients actually report.

What the Semaglutide Research Shows So Far

The centerpiece is a phase 2 trial published in 2025. In that randomized clinical trial of once-weekly semaglutide in adults with alcohol use disorder, 48 non-treatment-seeking participants got low-dose semaglutide or placebo across nine weeks.

The semaglutide group drank less during a laboratory self-administration task, reported fewer drinks per drinking day, and reported significantly lower weekly craving.

Those are real signals from a well-run trial. They also come from 48 people, over nine weeks, at doses well below what is typically used for weight management.

Sitting around that trial is a growing pile of observational work. Large database studies of people already on GLP-1 medications for diabetes or weight keep finding lower rates of alcohol-related diagnoses and hospital visits.

Observational data cannot prove cause. It can tell you a signal is worth chasing, and researchers are chasing it now with larger and longer trials.

The fair summary is short. Naltrexone is proven. Semaglutide is promising.

That difference should shape how you talk to a physician about it, which is something we get into further in our comparison of naltrexone and GLP-1 medications for alcohol use disorder.

Side Effects People Actually Notice

The side effect profiles are as different as the mechanisms behind them.

Naltrexone's common complaints are nausea, headache, dizziness, and fatigue. They usually fade inside the first week or two.

Taking it with food helps a lot. A physician can also start you at 25mg for a few days and step up, which takes the edge off the adjustment period.

The one hard rule with naltrexone involves opioids. Because it blocks opioid receptors, anyone taking opioid pain medication needs to be fully off them for seven to ten days first.

A physician also reviews liver function before writing the prescription.

GLP-1 side effects run mostly through the gut, and they tend to show up again with each dose increase. Nausea leads the list, followed by vomiting, constipation, diarrhea, reflux, and getting full much faster than usual.

Most of it is manageable and often settles as your body adapts to a given dose. On average it is more disruptive than what naltrexone causes, and it is the single most common reason people stop.

One more thing worth planning for. Because GLP-1 medications slow gastric emptying and cut food intake, a lot of people find alcohol hits harder and faster than it used to.

That is not a bonus effect. It is a reason to be careful about the first few drinks after starting.

Cost, Access, and the Practical Side

Naltrexone is generic and inexpensive. It is a daily tablet that ships in a plain envelope, with no cold chain, no needles, and no supply shortages.

Semaglutide is a different situation. Brand-name GLP-1 medications carry high list prices, and plans that cover them for diabetes or weight management will not cover them for drinking.

Off-label generally means out of pocket. That does not rule it out, but it belongs in the decision honestly rather than as a footnote.

There is also the question of what else you are treating. If weight, blood sugar, and drinking are all on the same list, one medication touching several of them changes the math considerably.

Who Tends to Do Better on Which

No test tells you the answer in advance. There are patterns, though, and they are useful.

Naltrexone tends to suit people whose core problem is that one drink turns into six. If the issue is losing the brakes once you start, blocking the reward loop directly is the most targeted tool available.

High craving intensity and a family history of alcohol problems both predict a good naltrexone response, which is a genuinely useful thing to know going in.

Semaglutide tends to appeal to people describing a steady, low-grade pull toward alcohol rather than a loss of control mid-session. The wine that is already poured before you decided to pour it.

It also fits people already carrying metabolic concerns, where the alcohol effect is a welcome addition to what they were treating anyway.

Our breakdown of why semaglutide reduces alcohol cravings goes deeper into that mechanism. If you are weighing a different GLP-1, our look at tirzepatide compared with naltrexone covers that side of the question.

Goals matter as much as biology. Naltrexone works for moderation and for stopping entirely, so neither medication requires you to declare abstinence to qualify for help.

Using Both Together Under One Physician

Treating this as a two-way choice is often the wrong frame. The medications do not compete for the same receptor, and some people do best with both.

A physician-guided combination pairs a GLP-1 medication with daily oral naltrexone. One lowers how much you want to drink. The other lowers what you get out of it when you do.

Choose Your Horizon supports both medications individually and together as an integrated solution, with combination plans starting at $399 a month and physicians reviewing every step.

We walk through the details in our guide to taking a GLP-1 and naltrexone together, including timing and what to watch for.

Combining anything raises the bar for supervision. Overlapping nausea, dose timing, liver monitoring, and titration schedules all need one physician looking at the whole picture instead of two prescribers working blind.

What This Comparison Means for You

Naltrexone is the medication with FDA approval for alcohol, thirty years of controlled trials, a mild side effect profile, and a price that does not require a conversation with your insurer.

Semaglutide is the medication with a promising early trial, sound biological logic, real cost, and no approval for drinking yet.

Neither one is willpower in a tablet. Both do their best work alongside coaching, tracking, and a clear picture of what you want your drinking to look like six months from now.

The clinical, neurological, and behavioral science here has moved a long way in a short time. What has not changed is that you do not need to hit a crisis point to ask about any of it.

Wanting to drink less is reason enough.

Frequently Asked Questions

Is semaglutide approved for alcohol use disorder?

No. Semaglutide is approved for type 2 diabetes and chronic weight management. Any use for drinking is off-label and depends on a physician's judgment.

Which works faster, semaglutide or naltrexone?

Naltrexone acts on the very first drink you take after a dose, and most people notice a difference within two to four weeks. GLP-1 effects build more slowly as the dose is titrated upward.

Can you take semaglutide and naltrexone at the same time?

Some people do, under physician supervision. They work through separate receptor systems, so there is no direct interaction, but overlapping nausea makes monitoring important.

Does naltrexone mean I have to quit drinking?

No. Naltrexone is used for moderation as often as for abstinence. Plenty of people take it specifically to drink less rather than to stop completely.

Will insurance cover a GLP-1 for drinking?

Usually not. Coverage generally follows approved indications, so off-label use for alcohol is typically paid out of pocket.

Is naltrexone safe to take long term?

It has a long safety record with daily use, no abuse potential, and no tolerance to its effect. Liver function is checked before starting and monitored during treatment.

Find out which medication fits your drinking, your health history, and your goals. Take the online Alcohol Use Assessment to see what a Choose Your Horizon physician recommends for you.